HIV prevention drug hailed as breakthrough, but who gets access? | Science and Technology News
A medicine injected just twice a year could transform the fight against HIV. In a 2024 clinical trial involving more than 2,000 young women in South Africa and Uganda, no participants who received lenacapavir contracted HIV. Recommended Stories list of 4 itemsend of list Developed by United States pharmaceutical company Gilead Sciences, the injectable drug…

